Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2025 08:16 ET | Source: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress

MELBOURNE, Australia and SAN FRANCISCO, May 07, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing...
May 07, 2025 08:00 ET | Source: Radiopharm Theranostics

Radiopharm Theranostics to Participate in the D. Boral Capital Inaugural Global Conference

SYDNEY, May 07, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, Nasdaq: RADX, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative...
May 07, 2025 00:10 ET | Source: Clinuvel Pharmaceuticals Limited

CLINUVEL recruits 200 patients in Phase III vitiligo trial CUV105

CLINUVEL has met its recruitment target in its phase III trial (CUV105) of SCENESSE® (afamelanotide 16mg) in vitiligo, with more than 200 patients enrolled
May 06, 2025 08:00 ET | Source: Novo Resources Corp.

Novo Resources Releases Updated Corporate Presentation

PERTH, West Australia, May 06, 2025 (GLOBE NEWSWIRE) -- Novo Resources Corp. (Novo or the Company) (ASX: NVO) (TSX: NVO) (OTCQB: NSRPF) is pleased to announce the release of its updated corporate...
May 05, 2025 09:11 ET | Source: Novo Resources Corp.

High Grade Gold Anomaly Extended at John Bull in Preparation for Drilling

HIGHLIGHTS Detailed mapping, soil sampling and rock chip sampling recently completed by Novo at the John Bull Gold Project follows previously reported outstanding results by TechGen Metals Limited...
May 05, 2025 08:00 ET | Source: Immutep Limited

Immutep’s Efti in Combination with KEYTRUDA® (pembrolizumab) Drives Strong Overall Survival in Head and Neck Cancer with CPS <1

Complementary nature of these two immunotherapies leads to excellent 17.6-month median Overall Survival in head and neck cancer patients with PD-L1 CPS <1Mature overall survival data builds on...
May 05, 2025 07:35 ET | Source: HAZER GROUP LIMITED

Hazer and KBR Enter Global Deal to Accelerate Licensing and Commercialisation

Highlights Binding strategic alliance with KBR (NYSE: KBR), a world-leading engineering group and global technology licensor set to supercharge Hazer’s commercialisation strategyHazer is KBR’s...
May 05, 2025 07:35 ET | Source: ALTERITY THERAPEUTICS LIMITED

Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy

– Fast Track Designation highlights potential of ATH434 to address high unmet need for individuals with MSA – MELBOURNE, Australia and SAN FRANCISCO, May 05, 2025 (GLOBE NEWSWIRE) -- Alterity...
May 05, 2025 07:00 ET | Source: Xanadu Mines Ltd.

Update to Zijin Put Option and Exclusivity Arrangements

TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu or the Company) refers to its announcement dated 7 April 2025 in relation to the Extension of the Zijin Put...
May 05, 2025 07:00 ET | Source: Mobilicom Limited

Mobilicom’s Cybersecure Drone and Robotics Solutions to Feature at Key U.S. Defense & Autonomy Industry Events

XPONENTIAL 2025 in Houston where Mobilicom CEO Oren Elkayam will deliver presentations on securing autonomous vehicles and navigating electromagnetic warfare Special Operations Forces (SOF) Week 2025...